Sponsor Pipeline

Ardelyx Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
4
Active Trials
1
Recruiting
3
Phase 3
Active Trials by Phase
Phase 3
3
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07382167 A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic… Chronic Idiopathic Constipation (CIC) Recruiting
NCT05643534 Study to Assess Safety and Efficacy of Tenapanor for Treatment of IBS-C in Pediatric… Irritable Bowel Syndrome With Constipation (IBS-C) Active, Not Recruiting
NCT05905926 Safety Study of Tenapanor for the Treatment of Pediatric Patients (6 to Less Than 18… Irritable Bowel Syndrome With Constipation (IBS-C) Enrolling by Invitation
Phase 2
NCT06553547 4-Week, Multi-center Dose-Ranging Study for the IBS-C in Pts. 6 to <12 Yrs Irritable Bowel Syndrome With Constipation (IBS-C) Active, Not Recruiting
Get alerts when Ardelyx's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free